drugset / Trial / NCT02519439
A Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset Seizures
NaSingle-groupOpen-labelTreatment
Summary
A follow-on, two-year open-label extension study of ganaxolone as add-on therapy in adult patients with drug-resistant partial-onset seizures
Timeline
- Start
- 2015-02
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ganaxolone | Small molecule | 450 mg | — |
| Subject | Ganaxolone | Small molecule | 900 mg | — |